Neuroradiology Unit and CERMAC, Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Eur Radiol. 2019 Jul;29(7):3467-3479. doi: 10.1007/s00330-019-06122-x. Epub 2019 Apr 10.
To compare dynamic contrast-enhanced MRI (DCE-MRI) data obtained using different prebolus T1 values in glioma grading and molecular profiling.
We retrospectively reviewed 83 cases of gliomas: 46 lower-grade gliomas (LGG; grades II and III) and 37 high-grade gliomas (HGG; grade IV). DCE-MRI maps of plasma volume fraction (Vp), extravascular-extracellular volume fraction (Ve), and tracer transfer constant from plasma to tissue (K) were obtained using a fixed T1 value of 1400 ms and a measured T1 obtained with variable flip angle (VFA). Tumour segmentations were performed and first-order histogram parameters were extracted from volumes of interest (VOIs) after co-registration with the perfusion maps. The two methods were compared using Wilcoxon matched-pairs signed-rank test and Bland-Altman analysis. Diagnostic accuracy was obtained and compared using ROC curve analysis and DeLong's test.
Perfusion parameters obtained with the fixed T1 value were significantly higher than those obtained with the VFA. As regards diagnostic accuracy, there were no significant differences between the two methods both for glioma grading and molecular classification, except for few parameters of both methods.
DCE-MRI data obtained with different prebolus T1 are not comparable and the definition of a prebolus T1 by T1 mapping is not mandatory since it does not improve the diagnostic accuracy of DCE-MRI.
• DCE-MRI data obtained with different prebolus T1 are significantly different, thus not comparable. • The definition of a prebolus T1 by T1 mapping is not mandatory since it does not improve the diagnostic accuracy of DCE-MRI for glioma grading. • The use of a fixed T1 value represents a valid alternative to T1 mapping for DCE-MRI analysis.
比较不同预注 T1 值下获得的动态对比增强磁共振成像(DCE-MRI)数据在胶质瘤分级和分子谱分析中的应用。
我们回顾性分析了 83 例胶质瘤患者:46 例低级别胶质瘤(LGG;II 级和 III 级)和 37 例高级别胶质瘤(HGG;IV 级)。使用固定 T1 值 1400ms 和测量的可变翻转角(VFA)获得血浆容积分数(Vp)、血管外细胞外容积分数(Ve)和从血浆到组织的示踪剂转移常数(K)的 DCE-MRI 图。对肿瘤进行分段,并在与灌注图配准后从感兴趣体积(VOI)中提取一阶直方图参数。使用 Wilcoxon 配对符号秩检验和 Bland-Altman 分析比较两种方法。使用 ROC 曲线分析和 DeLong 检验获得诊断准确性并进行比较。
使用固定 T1 值获得的灌注参数明显高于使用 VFA 获得的参数。就诊断准确性而言,两种方法在胶质瘤分级和分子分类方面均无显著差异,除了两种方法的少数参数外。
不同预注 T1 值获得的 DCE-MRI 数据不可比,并且 T1 映射定义预注 T1 不是强制性的,因为它不会提高 DCE-MRI 的诊断准确性。
不同预注 T1 值获得的 DCE-MRI 数据差异显著,因此不可比。
T1 映射定义预注 T1 不是强制性的,因为它不会提高 DCE-MRI 对胶质瘤分级的诊断准确性。
使用固定 T1 值代表了 DCE-MRI 分析的 T1 映射的有效替代方法。